Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fecal microbiota transplant (Hospital Universitario Dr. Jose E. Gonzalez)
- Development stage
- Preclinical
- Lead developer
- Hospital Universitario, Dr. José
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Fecal microbiota transplant is a biologic, live microbial therapy being investigated by the Hospital Universitario Dr. Jose E. Gonzalez for the treatment of chronic kidney disease (CKD). [1, 2, 3, 4] Administered as oral capsules containing fecal microbiota from healthy donors, the intervention aims to restore a healthy gut microbiome. [2-1, 2-7] This is intended to modulate the dysregulated gut-kidney axis, which may in turn decrease inflammation and slow the progression of CKD in patients with the disease, particularly those with underlying diabetes and/or hypertension. [1-2, 1-3, 2-9, 2-19] A double-blind, randomized, placebo-controlled clinical trial (NCT04361097) is evaluating this therapeutic strategy in patients with CKD stages 2, 3, and 4. [1, 2-9, 2-19]
- Other names
- fecal microbiota-Hospital Universitario Dr. Jose E. Gonzalez-chronic kidney diseaseFecal Microbiota Transplantation
Beyond the preview
Go deeper on fecal microbiota transplant (Hospital Universitario Dr. Jose E. Gonzalez).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fecal microbiota transplant (Hospital Universitario Dr. Jose E. Gonzalez).